Elite Wealth Management’s Gilead Sciences GILD Stock Holding History

Elite Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.92M	Buy	15,232 +4,764	+46%	+$628K	0.57%	25
2026 Q1	$1.46M	Buy	10,468 +359	+4%	+$50.3K	0.47%	25
2025 Q4	$1.24M	Buy	10,109 +300	+3%	+$36.5K	0.34%	30
2025 Q3	$1.09M	Buy	+9,809	New	+$1.11M	0.28%	31
2018 Q1	–	Sell	-3,379	Closed	-$242K	–	61
2017 Q4	$242K	Buy	+3,379	New	+$257K	0.2%	55
2016 Q3	$166K	Buy	+2,100	New	+$171K	0.27%	41
2015 Q4	–	Sell	-9,777	Closed	-$960K	–	52
2015 Q3	$960K	Sell	9,777 -8,897	-48%	-$988K	1.51%	20
2015 Q2	$2.19M	Buy	18,674 +5,699	+44%	+$623K	2.26%	8
2015 Q1	$1.27M	Buy	+12,975	New	+$1.32M	1.13%	32
2014 Q2	–	Sell	-100	Closed	-$7.78K	–	465
2014 Q1	$7K	Buy	+100	New	+$7.84K	0.01%	259

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Elite Wealth Management's GILD Position: Q2 2026 in Review

Elite Wealth Management increased its Gilead Sciences (GILD) stake by 46% in Q2 2026, buying an estimated $628K and bringing the position to 15,232 shares worth $1.92M. The position accounts for 0.57% of the portfolio, ranked #25.

Elite Wealth Management first reported a position in GILD in Q1 2014 and has held it in 10 quarters since. The position peaked at $2.19M in Q2 2015. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Elite Wealth Management held 15,232 shares of Gilead Sciences worth $1.92M as of Q2 2026.
Elite Wealth Management bought 4,764 Gilead Sciences shares in Q2 2026, an estimated $628K.
Gilead Sciences made up 0.57% of Elite Wealth Management's portfolio in Q2 2026, its #25 holding.
Elite Wealth Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 10 quarters since.
Elite Wealth Management's Gilead Sciences position peaked at $2.19M in Q2 2015.
2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Elite Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.